Engineering a bioresorbable stent: REVA programme update

EuroIntervention

Volumn 5, Issue SUPPL. F, 2009, Pages

  Matthew J, Pollman ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(DESAMINOTYROSYL TYROSINE ETHYL ESTER CARBONATE); POLYMER; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

BIODEGRADABILITY; BIODEGRADABLE IMPLANT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EQUIPMENT DESIGN; HUMAN; IN-STENT RESTENOSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; STENT THROMBOSIS; SURVIVAL RATE; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 77956159301     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijv5ifa9     Document Type: Review

References (19)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M, for The Benestent Study Group et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease: the BENESTENT study group. N Eng J Med. 1994;331:489-495. (Pubitemid 24256751)
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for The Stent Restenosis Study Investigators et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Eng J Med. 1994;331: 496-501. (Pubitemid 24256752)
3. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43. (Pubitemid 126426397)
4. Zimmer S, Jacobs B, Levy T, Robins J. Med Tech 101: The Medical Device Handbook. 2002, Deutsche Bank Securities, Inc.: North America. p. 1-70.
5. Gunn J, Cumberland D. Stent coatings and local drug delivery. State of the art. Eur Heart J, 1999;20:1693-1700.
6. Hamon M, Lécluse E, Monassier JP, Grollier G, Potier JC. Pharmacological approaches to the prevention of restenosis after coronary angioplasty. Drugs Aging, 1998;13:291-301. (Pubitemid 28493007)
7. Babapulle MN, Eisenberg M.J. Coated stents for the prevention of restenosis: Part I. Circulation. 2002;106:2859-66. (Pubitemid 35396988)
8. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part II. Circulation. 2002;106:2734-40. (Pubitemid 35364930)
9. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia- Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
10. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. (Pubitemid 351384734)
11. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JH, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988;77:361-71.
12. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816-2821.
13. Zeltinger J, Schmid E, Brandom D, Bolikal D, Pesnell A, Kohn J. Advances in the Development of Coronary Stents. Society For Biomaterials, Biomaterials Forum. 2004;26:8,9,24.
14. Kohn J, Zeltinger J. Resorbable, drug-eluting stents: A new frontier in the treatment of coronary artery disease. Expert Review of Medical Devices. 2005;2:667-671. (Pubitemid 41699897)
15. Shymko MJ. Reactions to iodinated contrast. Radiol Technol. 2001;72:381-2.
16. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol. 2000;10:1965-75.
17. Hash RB. Intravascular radiographic contrast media: issues for family physicians. J Am Board Fam Pract. 1999;12:32-42. (Pubitemid 29238698)
18. Abizaid A, Brito A, Costa R. Stent Pipeline: An Update on Absorbable Polymer Stents. J Cardiac Interventions Today. 2008;2:56-62.
19. Kalmár G, Hübner F, Voelker W, Hutzenlaub J, Teubner J, Poerner T, Süselbeck T, Borggrefe M, Haase KK. "Radial Force and Wall Apposition of Balloon Expandable Vascular Stents in Eccentric Stenosis: An In Vitro Evaluation in a Curved Vessel Model." J Vasc Interv Radiol. 2002;13:499-508. (Pubitemid 34526289)